Comments
Loading...

LISKA BIOMETRY INC by Liska Biometry, Inc. Analyst Ratings

LSKAOTCGM
Logo brought to you by Benzinga Data

LISKA BIOMETRY INC by Liska Biometry, Inc. Analyst Ratings and Price Targets | OTC:LSKA | Benzinga

LISKA BIOMETRY INC by Liska Biometry, Inc. Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for LISKA BIOMETRY INC by Liska Biometry, Inc. Corp from these most-recent analyst ratings.

Analyst Ratings for LISKA BIOMETRY INC by Liska Biometry, Inc.

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for LISKA BIOMETRY INC by Liska Biometry, Inc. (LSKA) stock?

A

There is no price target for LISKA BIOMETRY INC by Liska Biometry, Inc.

Q

What is the most recent analyst rating for LISKA BIOMETRY INC by Liska Biometry, Inc. (LSKA)?

A

There is no analyst for LISKA BIOMETRY INC by Liska Biometry, Inc.

Q

When was the last upgrade for LISKA BIOMETRY INC by Liska Biometry, Inc. (LSKA)?

A

There is no last upgrade for LISKA BIOMETRY INC by Liska Biometry, Inc.

Q

When was the last downgrade for LISKA BIOMETRY INC by Liska Biometry, Inc. (LSKA)?

A

There is no last downgrade for LISKA BIOMETRY INC by Liska Biometry, Inc..

Q

When is the next analyst rating going to be posted or updated for LISKA BIOMETRY INC by Liska Biometry, Inc. (LSKA)?

A

There is no next analyst rating for LISKA BIOMETRY INC by Liska Biometry, Inc..

Q

Is the Analyst Rating LISKA BIOMETRY INC by Liska Biometry, Inc. (LSKA) correct?

A

There is no next analyst rating for LISKA BIOMETRY INC by Liska Biometry, Inc..

Browse analyst ratings and price targets on all stocks.